Influence
January 9, 2020

Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners

Eneida Mendonca, Regenstrief Institute, VP for Research DevelopmentRegenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI.  The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”

Related News

Silhouette of woman with a walker casting the shadow of a child

Supportive later-life social relationships mediate the risk of severe frailty in adults who had negative childhood experiences

Frailty is a serious concern in later-life adults due to its association with additional health risks including disability, falls,

infographics showing eight conditions identified by the researchers

COVID-infected adults with 4 or more underlying diseases or advanced age face higher risk of ICU stay, death

10-state June 2021-March 2023 study from CDC’s VISION Network identifies risk factors for critical outcomes Whether vaccinated or not,